Página 1 dos resultados de 3305 itens digitais encontrados em 0.010 segundos
Resultados filtrados por Publicador: BioMed Central Ltd.

Enhanced invitation methods to increase uptake of NHS health checks: study protocol for a randomized controlled trial

Forster, Alice S.; Burgess, Caroline; McDermott, Lisa; Wright, Alison J.; Dodhia, Hiten; Conner, Mark; Miller, Jane; Rudisill, Caroline; Cornelius, Victoria; Gulliford, Martin C.
Fonte: BioMed Central Ltd. Publicador: BioMed Central Ltd.
Tipo: Article; PeerReviewed Formato: application/pdf
Publicado em 30/08/2014 EN; EN
Relevância na Pesquisa
Background: NHS Health Checks is a new program for primary prevention of heart disease, stroke, diabetes, chronic kidney disease, and vascular dementia in adults aged 40 to 74 years in England. Individuals without existing cardiovascular disease or diabetes are invited for a Health Check every 5 years. Uptake among those invited is lower than anticipated.Method: The project is a three-arm randomized controlled trial to test the hypothesis that enhanced invitation methods, using the Question-Behaviour Effect (QBE), will increase uptake of NHS Health Checks compared with a standard invitation. Participants comprise individuals eligible for an NHS Health Check registered in two London boroughs. Participants are randomized into one of three arms. Group A receives the standard NHS Health Check invitation letter, information sheet, and reminder letter at 12 weeks for nonattenders. Group B receives a QBE questionnaire 1 week before receiving the standard invitation, information sheet, and reminder letter where appropriate. Group C is the same as Group B, but participants are offered a £5 retail voucher if they return the questionnaire. Participants are randomized in equal proportions, stratified by general practice. The primary outcome is uptake of NHS Health Checks 6 months after invitation from electronic health records. We will estimate the incremental health service cost per additional completed Health Check for trial groups B and C versus trial arm A...